AR Copy Number and AR Signaling-directed Therapies in Castrationresistant Prostate Cancer

E-ISSN： 1873-5576|18|9|869-876

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.9, 2018-11, pp. : 869-876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapies for prostate cancer

By Asatiani Ekatherine Gelmann Edward P

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 283-298

Informa Healthcare

Access to resources Recommend Favorite

Cholesterol as a Potential Target for Castration-Resistant Prostate Cancer

By Twiddy Alexis Leon Carlos Wasan Kishor

Pharmaceutical Research, Vol. 28, Iss. 3, 2011-03 ,pp. : 423-437

Springer Publishing Company

Access to resources Recommend Favorite

Sipuleucel-T: In Metastatic Castration-Resistant Prostate Cancer

By Plosker Greg L.

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Abiraterone Acetate: In Metastatic Castration-Resistant Prostate Cancer

By Yang Lily P.H.

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 2067-2077

Adis International

Access to resources Recommend Favorite

Quo vadis: Advanced prostate cancer—clinical care and clinical research in the era of multiple androgen receptor-directed therapies

By Kim Won Ryan Charles J.

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 361-371

Blackwell Publishing

Access to resources Recommend Favorite